| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Interim President &CEO | See Remarks
1 company
Gould Robert J is a Director at FULC. Recent filings cover 0 purchases and 29 sales. Those positions are worth an estimated $4.9M at current prices.
Our model assigns Gould Robert J a strong insider score of 85/100, based on 13 past trades. Over a 12-month horizon, 81.8% of those trades were profitable, with an average 12-month return of +52.0%.
Gould Robert J's largest disclosed position is in FULC as Director, worth about $4.9M. The recent filings there lean toward selling, a net 340,420 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 20, 2021 | FULC Fulcrum Therapeutics, Inc. | See Remarks | Sell | 10,000 | $12.08 | $120,826.00 | -1.9% | |
| Jul 8, 2020 | FULC Fulcrum Therapeutics, Inc. | See Remarks | Sell | 2,500 | $20.00 | $50,000.00 | -0.5% | |
| Jun 25, 2020 | FULC Fulcrum Therapeutics, Inc. | See Remarks | Sell | 2,500 | $20.80 | $51,992.00 | -0.5% | |
| Jun 9, 2020 | FULC Fulcrum Therapeutics, Inc. | See Remarks | Sell | 156 | $20.00 | $3,120.00 | - | |
| Jun 5, 2020 | FULC Fulcrum Therapeutics, Inc. | See Remarks | Sell | 3,433 | $20.17 | $69,251.16 | -0.6% | |
| Jun 4, 2020 | FULC Fulcrum Therapeutics, Inc. | See Remarks | Sell | 2,800 | $20.09 | $56,250.43 | -0.5% | |
| Jun 2, 2020 | FULC Fulcrum Therapeutics, Inc. | See Remarks | Sell | 2,802 | $20.00 | $56,040.00 | -0.5% | |
| May 29, 2020 | FULC Fulcrum Therapeutics, Inc. | See Remarks | Sell | 3,309 | $20.04 | $66,301.91 | -0.6% | |
| May 26, 2020 | FULC Fulcrum Therapeutics, Inc. | See Remarks | Sell | 2,500 | $20.00 | $50,000.00 | -0.5% | |
| Feb 19, 2020 | FULC Fulcrum Therapeutics, Inc. | See Remarks | Sell | 2,500 | $20.00 | $50,000.00 | -0.4% |